Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 4;44(4):461-6.
doi: 10.1038/ng.1107.

A New Subtype of Bone Sarcoma Defined by BCOR-CCNB3 Gene Fusion

Affiliations
Free article

A New Subtype of Bone Sarcoma Defined by BCOR-CCNB3 Gene Fusion

Gaëlle Pierron et al. Nat Genet. .
Free article

Abstract

The identification of subtype-specific translocations has revolutionized the diagnostics of sarcoma and has provided new insight into oncogenesis. We used RNA-seq to investigate samples from individuals diagnosed with small round cell tumors of bone, possibly Ewing sarcoma, but which lacked the canonical EWSR1-ETS translocation. A new fusion was observed between BCOR (encoding the BCL6 co-repressor) and CCNB3 (encoding the testis-specific cyclin B3) on the X chromosome. RNA-seq results were confirmed by RT-PCR and through cloning of the tumor-specific genomic translocation breakpoints. In total, 24 BCOR-CCNB3-positive tumors were identified among a series of 594 sarcoma cases. Gene profiling experiments indicated that BCOR-CCNB3-positive cases are biologically distinct from other sarcomas, particularly Ewing sarcoma. Finally, we show that CCNB3 immunohistochemistry is a powerful diagnostic marker for this subgroup of sarcoma and that overexpression of BCOR-CCNB3 or of truncated CCNB3 activates S phase in NIH3T3 cells. Thus, the intrachromosomal X-chromosome fusion described here represents a new subtype of bone sarcoma caused by a newly identified gene fusion mechanism.

Comment in

Similar articles

See all similar articles

Cited by 93 articles

See all "Cited by" articles

References

    1. EMBO J. 1994 Feb 1;13(3):595-605 - PubMed
    1. Blood. 2011 Dec 1;118(23):6153-63 - PubMed
    1. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 - PubMed
    1. Blood. 2010 Nov 18;116(20):4274-83 - PubMed
    1. Nat Methods. 2008 Jul;5(7):621-8 - PubMed

MeSH terms

Associated data

Feedback